Biotech Healthcare Colombia

What Biotech Healthcare Colombia does

Biotech Healthcare Colombia appears to be a Colombian commercial entity (8 employees, Bogotá) affiliated with Biotech Healthcare Group, a privately-held global medical device company founded in 1999 and headquartered in Luzern, Switzerland. The parent organization operates across three healthcare verticals — ophthalmology, orthopedics, and aesthetics — with R&D centers and manufacturing facilities in Roscommon, Ireland and Ahmedabad, India. The company sells intraocular lenses (including cataract monofocal/toric/EDOF and phakic refractive lenses branded Eyecryl and Optiflex), ophthalmic viscosurgical devices (OVDs), vitreoretinal products (dyes, tamponades), viscosupplements for osteoarthritis (Optivisc), and hyaluronic acid dermal fillers, distributing through direct enterprise field sales to hospitals, eye clinics, orthopedic practices, and aesthetic clinics across 110+ countries.

The company's underlying technology rests on proprietary formulations in intraocular lens optics, phakic collamer lens design, hyaluronic acid viscosupplementation chemistry, and surgical device manufacturing. Recent product innovation includes the September 2025 launch of Optiflex XTENSE Comfort Plus, an extended-depth-of-focus IOL introduced at the ESCRS congress in Copenhagen. Marketing is conducted through a nine-language corporate website, mobile application (Biotech Connect), surgeon testimonial video series (Biotech Coffee Chat), a patient-facing Vision Simulator tool, and presence at major ophthalmology conferences.

The business model is hardware/consumable medical device sales through quote-based direct sales channels. Pricing is not publicly disclosed. Revenue derives from durable device placements (IOLs, phakic lenses) alongside recurring consumables (OVDs, viscosupplements, dermal fillers, surgical dyes). The firm is privately held with no parent company, no disclosed institutional investors, and no public funding rounds — it has operated independently for 25 years.

Name

Biotech Healthcare Colombia

Legal name

Biotech Healthcare Group

Website

https://biotechvisioncare.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

Biotech Healthcare Colombia is a Bogotá-based affiliate of Biotech Healthcare Group, a privately-held global medical device company selling intraocular lenses, ophthalmic viscosurgical devices, viscosupplements, and dermal fillers to healthcare providers across 110+ countries.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)

akta.pro secondary industry

Ophthalmology Pharmaceuticals (HLAIAAAL)

Keywords

• Ophthalmic medical devices
• Intraocular lenses
• Orthopedic viscosupplements
• Dermal fillers
• Cataract surgical products

Headquarters

HQ city

Luzern

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Medical Device Sales: Biotech Healthcare generates revenue through the sale of medical devices and consumables to healthcare providers globally. The company sells ophthalmic products (IOLs, OVDs, surgical supplies), orthopedic viscosupplements, and aesthetic dermal fillers to hospitals, clinics, and surgeons. Revenue is derived from both product sales and likely includes recurring consumables alongside durable device placements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Biotech Healthcare Group manufactures and sells medical devices across three verticals: ophthalmology (intraocular lenses, OVDs, vitreoretinal products, riboflavin, intrastromal corneal ring segments), orthopedics (hyaluronic acid viscosupplements such as OPTIVISC for osteoarthritis), and aesthetics (hyaluronic acid dermal fillers). The company sells directly to hospitals, eye clinics, orthopedic practices, and aesthetic practitioners in more than 110 countries.

Product overview

Biotech Healthcare Group is a global healthcare company founded in 1999, operating across three healthcare verticals: Ophthalmology, Orthopedics, and Aesthetics. The Ophthalmology division offers advanced intraocular lenses (IOLs) including cataract solutions (monofocal, toric, EDOF), refractive phakic lenses (Eyecryl PHAKIC), OVDs, vitreoretinal products (dyes, temponades), ISCR, and riboflavin. The Orthopedics division provides viscosupplement solutions (OPTIVISC, OPTIVISC Single) for joint pain and mobility restoration. The Aesthetics division delivers hyaluronic acid-based dermal fillers. The company serves patients in more than 110 countries with sales/marketing headquartered in Luzern, Switzerland, and manufacturing facilities in Roscommon, Ireland and Ahmedabad, India.

Differentiator

Problem solved

Functional benefit

Brands

• Eyecryl: Intraocular lenses (IOLs) product line including cataract and refractive lenses
• Optiflex
• Optivisc

Products and services

• Intraocular Lenses (IOLs) Advanced cataract intraocular lenses including monofocal and toric options for cataract surgery, marketed to ophthalmologists and eye surgeons.
• Optiflex Genesis Advanced intraocular lens used in cataract surgery as part of the cataract product range, targeting ophthalmic surgeons.
• Optiflex TRIO Intraocular lens for cataract patients, positioned as a high-performance solution for cataract surgery outcomes.
• Optiflex XTENSE Comfort Plus Next-generation extended-depth-of-focus (EDOF) intraocular lens designed for cataract surgery patients, launched in September 2025.
• Eyecryl PHAKIC Phakic intraocular lens (implantable collamer lens) for refractive correction, designed for patients with insufficient corneal thickness or high prescriptions unsuitable for laser treatment.
• OVDs (Ophthalmic Viscosurgical Devices) Viscoelastic solutions used during ophthalmic surgical procedures to protect intraocular tissues and maintain surgical space.
• ISCR (Intrastromal Corneal Ring Segments) Corneal ring segments used for refractive correction of conditions such as keratoconus, sold to refractive surgeons.
• Riboflavin Riboflavin solution used in corneal cross-linking procedures for refractive and keratoconus treatment.
• Ophthalmic Dyes Ophthalmic dyes for surgical visualization during cataract and other eye procedures.
• Vitreoretinal Dyes Specialized dyes used for visualization during vitreoretinal surgical procedures.
• Temponades Tamponading agents used during vitreoretinal surgery to support the retina post-operatively.
• OPTIVISC Hyaluronic acid viscosupplement (multi-shot) for intra-articular injection to restore synovial fluid balance in osteoarthritis, sold to orthopedic surgeons and specialists.
• OPTIVISC Single Single-shot hyaluronic acid viscosupplement designed to restore joint mobility and alleviate pain associated with osteoarthritis.
• Hyaluronic Acid Dermal Fillers Premium hyaluronic acid-based dermal fillers for facial aesthetic enhancements including wrinkle reduction and volume restoration, sold to aesthetic practitioners.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Rayner Intraocular Lenses: Rayner is a UK-based specialist IOL manufacturer with monofocal, toric and multifocal/EDOF IOLs (RayOne, Sulcoflex), directly comparable to Biotech Healthcare's Optiflex and EDOF cataract portfolio.
• Galderma: Galderma is a global leader in hyaluronic-acid-based aesthetic dermal fillers (Restylane, Emervel). It directly competes with Biotech Healthcare's premium HA-based aesthetic dermal filler line in the medical aesthetics channel.
• Carl Zeiss Meditec: Carl Zeiss Meditec provides ophthalmic surgical microscopes, IOLs (CT SPHERIS, CT TORIC), and OVDs through its cataract suite. Overlapping IOL and surgical consumable SKUs make it a direct competitor in the same surgeon channels.
• Alcon: Alcon is the world's leading IOL and ophthalmic surgical device manufacturer, offering a full cataract suite (monofocal, toric, EDOF/PC-IOLs) plus OVDs and vitreoretinal products. It directly competes with Biotech Healthcare across every surgical ophthalmology SKU in its portfolio.
• STAAR Surgical: STAAR Surgical is the leading manufacturer of phakic intraocular lenses (Visian ICL), competing head-to-head with Biotech Healthcare's Eyecryl PHAKIC product for patients unsuitable for laser vision correction.
• Anika Therapeutics: Anika manufactures hyaluronic-acid viscosupplements (Orthovisc, Monovisc, Cingal) for osteoarthritis joint pain, directly competing with Biotech Healthcare's OPTIVISC and OPTIVISC Single orthopedic franchise.
• Johnson & Johnson Vision (AMO/JJVC): Johnson & Johnson Vision, through its AMO/Abbott Medical Optics heritage, sells TECNIS monofocal, toric and multifocal/EDOF IOLs plus cataract surgical packs. It is one of the top three global IOL competitors and competes head-on with Biotech Healthcare's cataract portfolio.
• SIFI Medtech: SIFI is an Italian ophthalmic company producing IOLs, OVDs, and intraocular dyes, overlapping with Biotech Healthcare's cataract and vitreoretinal surgical offerings, particularly in European and Latin American markets.
• Bausch + Lomb: Bausch + Lomb's surgical segment sells IOLs (including enVista and Toric lines), OVDs, and other cataract consumables, overlapping directly with Biotech Healthcare's Optiflex and OVD offerings. It is a fully integrated competitor across cataract and vitreoretinal surgery.

Emerging players

• VSY Biotechnology: VSY Biotechnology is an emerging Turkish-anchored ophthalmic firm offering IOLs (including trifocal/EDOF), OVDs, and viscoelastic products. It targets similar emerging-market and value-tier ophthalmic segments as Biotech Healthcare.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biotechcol

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotech Healthcare Colombia